Lannett stock has struggled lately due to opioid litigation and a weakening of its earnings forecast back in November. However, the company announced several product launches in December and early January, and today Lannett got FDA approval for, of all things, a cocaine-based anesthetic nasal spray. The stock has shown little positive reaction to any of this news,...
Don't have to be a genius to see that this will have some level of pullback. Although, specifically, I'll target 7 and add to my short if it goes over 12.
On August 27, Lannett Company reported its fourth-quarter earnings results. The company reported revenues of $133.84 million, a year-over-year decline of 21.69%. However, this was $13.56 million higher than the consensus estimate. The company also reported non-GAAP EPS (earnings per share) of $0.37. This is $0.16 higher than the consensus.
Lannett Company has...
With an intraday move of currently 42.81%, and intraday high of $8.95 and a short float percentage of 74.27% LCI looks like an interesting short-squeeze opportunity. The RSI indicated several overbought conditions with a cross at the 69.95 level, that followed a sharp sell-off. If you are interested in finding optimal RSI levels for individual stocks, please check...
This isn't just any double bottom. This is a double bottom in a penny stock with awesome analyst ratings and some of the biggest short squeeze potential in the market right now. When this runs, it could run fast.
Potential Long setup on LCI; awaiting price confirmation at a higher level - high risk trade profile contingent on upcoming earnings. Hope to see price break higher on positive earnings report.
Trade responsibly; TPs and SLs
In weekly TF looked cooked enough and below lows, MACD building trend up while the price itself stay the same.
in 4H same thing .
Balance sheet seem decent enough and with some luck well get some positive news about the pipeline .
first destination around 17$ and with a lot of luck maybe well get 20 +
good luck
not a recomandation to do anything in the stock...
Good company with positive chart indicators that had 41% short interest on 2/28.. big gap up at $19.75. Holding $16.35 and will sell if falls below $15 and take aanother look if and when it hits $18.35 (~12%)
LCI going up forming a bump & run or falling angel type of pattern. Moneyflow is accumulating & turning to positive side. We think it will continue up trend for a while.
Investors seems very bullish on this as Calls outnumbered puts by a bullish 31-to-1 ratio.
So we would consider $25 November Calls currently $1.30 or $25 December Calls currently $1.90
You...
Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Philadelphia, PA.
LCI
